A month ago more than 30 Civil Society organisations reached out to the European Commission asking for a strong EU engagement to tackle the issue of medicines shortages. Now, the EU Civil Society Forum on HIV, Hepatitis and TB working group on access to medicines is inviting you to contribute to a short survey on medicines shortages for the treatment of hepatitis B and C, HIV and TB as well as Opioid Substitution Therapy (OST) in 2019.
The data collected and summarised will be used to advocate for a comprehensive investigation into the causes of shortages in order to improve understanding of the situations and to seek for possible solutions.
The survey is not limited to EU countries.
The deadline for contribution is 27 June 23:59 CET.
Purpose of the survey:
To document medicines shortages in EU countries from the perspective of civil society working with affected communities.
To support a request to the European Commission to investigate the factors leading to medicines shortages to increase understanding of the situation and possible solutions.
The survey is carried out by :
The Civil Society Forum on HIV, TB and Hep (CSF) – an advisory body to the European Commission. The CSF facilitates the participation of NGOs in policy development and implementation, as well as to support the exchange of information and best practices across countries and settings.
About medicines shortages:
Shortages of pharmaceuticals can affect the health of patients. They are due to different factors, including unavailability on the market despite registration; withdrawal of the medicine from the market; manufacturing difficulties; problems affecting the quality of medicines or a safety concern; parallel trade; lack of continuity within the supply chain of pharmaceuticals.